Cargando…
Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition—Evidence for the Role for TG1 in Osteoclast Formation
Osteoclasts are multinucleated, bone-resorbing giant cells derived from monocyte–macrophage cell lines. Increased bone resorption results in loss of bone mass and osteoporosis. Osteoclast and bone marrow macrophages have been shown to express three TG enzymes (TG2, Factor XIII-A, and TG1) and TG act...
Autores principales: | Ebrahimi Samani, Sahar, Kaartinen, Mari T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487146/ https://www.ncbi.nlm.nih.gov/pubmed/37681871 http://dx.doi.org/10.3390/cells12172139 |
Ejemplares similares
-
Discovery and
Characterization of PROTACs Targeting
Tissue Transglutaminase (TG2)
por: Valdivia, Andres, et al.
Publicado: (2023) -
Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase
por: Gates, Eric W. J., et al.
Publicado: (2023) -
Dihydroisoxazole inhibitors of Anopheles gambiae seminal transglutaminase AgTG3
por: Le, Binh V, et al.
Publicado: (2014) -
Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease
por: Martucciello, Stefania, et al.
Publicado: (2020) -
Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
por: Mehta, Kapil, et al.
Publicado: (2011)